{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:20:52Z","timestamp":1791066052542,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T00:00:00Z","timestamp":1325721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1245\/s10434-011-2194-1","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T17:00:23Z","timestamp":1325696423000},"page":"2753-2762","source":"Crossref","is-referenced-by-count":93,"title":["UHRF1 Promotes Cell Growth and Metastasis Through Repression of p16ink4a in Colorectal Cancer"],"prefix":"10.1245","volume":"19","author":[{"given":"Feng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Zhang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Pat","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Long","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,5]]},"reference":[{"key":"2194_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277\u2013300.","journal-title":"CA Cancer J Clin"},{"key":"2194_CR2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ijc.11300","volume":"106","author":"L Yang","year":"2003","unstructured":"Yang L, Parkin DM, Li L, et al. Time trends in cancer mortality in China, 1987\u20131999. Int J Cancer. 2003;106:771\u201383.","journal-title":"Int J Cancer"},{"key":"2194_CR3","first-page":"121","volume":"60","author":"R Hopfner","year":"2000","unstructured":"Hopfner R, Mousli M, Jeltsch JM, et al. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res. 2000;60:121\u20138.","journal-title":"Cancer Res"},{"key":"2194_CR4","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1038\/sj.onc.1208053","volume":"23","author":"M Unoki","year":"2004","unstructured":"Unoki M, Nishidate T, Nakamura Y. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene. 2004;23:7601\u201310.","journal-title":"Oncogene"},{"key":"2194_CR5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nature06397","volume":"450","author":"J Sharif","year":"2007","unstructured":"Sharif J, Muto M, Takebayashi S, et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature. 2007;450:908\u201312.","journal-title":"Nature"},{"key":"2194_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4161\/epi.4.1.7370","volume":"4","author":"H Hashimoto","year":"2009","unstructured":"Hashimoto H, Horton JR, Zhang X, Cheng X. UHRF1, a modular multi-domain protein, regulates replication-coupled crosstalk between DNA methylation and histone modifications. Epigenetics. 2009;4:8\u201314.","journal-title":"Epigenetics"},{"key":"2194_CR7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2007.06.003","volume":"115","author":"C Bronner","year":"2007","unstructured":"Bronner C, Achour A, Arima Y, Chataigneau T, Saya H, Schini-Kerth VB. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther. 2007;115:419\u201334.","journal-title":"Pharmacol Ther"},{"key":"2194_CR8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bcp.2009.05.035","volume":"78","author":"M Unoki","year":"2009","unstructured":"Unoki M, Brunet J, Mousli M. Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem Pharmacol. 2009;78:279\u201388.","journal-title":"Biochem Pharmacol"},{"key":"2194_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1756-9966-30-41","volume":"30","author":"M Alhosin","year":"2011","unstructured":"Alhosin M, Sharif T, Mousli M, et al. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J Exp Clin Cancer Res. 2011;30:41.","journal-title":"J Exp Clin Cancer Res"},{"key":"2194_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3322\/canjclin.54.6.295","volume":"54","author":"CC Compton","year":"2004","unstructured":"Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004;54:295\u2013308.","journal-title":"CA Cancer J Clin"},{"key":"2194_CR11","first-page":"2615","volume":"50","author":"OH Beahrs","year":"1982","unstructured":"Beahrs OH. Colorectal cancer staging as a prognostic feature. Cancer. 1982;50:2615\u20137.","journal-title":"Cancer"},{"key":"2194_CR12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00428-007-0466-8","volume":"451","author":"I Zlobec","year":"2007","unstructured":"Zlobec I, Terracciano L, Jass JR, Lugli A. Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer. Virchows Arch. 2007;451:763\u20139.","journal-title":"Virchows Arch"},{"key":"2194_CR13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1053\/j.gastro.2005.08.012","volume":"129","author":"T Crnogorac-Jurcevic","year":"2005","unstructured":"Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, et al. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology. 2005;129:1454\u201363.","journal-title":"Gastroenterology"},{"key":"2194_CR14","first-page":"666","volume":"52","author":"Y Komuro","year":"2005","unstructured":"Komuro Y, Watanabe T, Tsurita G, Muto T, Nagawa H. Evaluating the combination of molecular prognostic factors in tumor radiosensitivity in rectal cancer. Hepatogastroenterology. 2005;52:666\u201371.","journal-title":"Hepatogastroenterology"},{"key":"2194_CR15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF02722955","volume":"32","author":"MP Moyer","year":"1996","unstructured":"Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim. 1996;32:315\u20137.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2194_CR16","doi-asserted-by":"crossref","first-page":"44464","DOI":"10.1074\/jbc.M104942200","volume":"276","author":"D Zhao","year":"2001","unstructured":"Zhao D, Keates AC, Kuhnt-Moore S, Moyer MP, Kelly CP, Pothoulakis C. Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes. J Biol Chem. 2001;276:44464\u201371.","journal-title":"J Biol Chem"},{"key":"2194_CR17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"2194_CR18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.humpath.2005.07.016","volume":"36","author":"M Lorenzato","year":"2005","unstructured":"Lorenzato M, Caudroy S, Bronner C, et al. Cell cycle and\/or proliferation markers: What is the best method to discriminate cervical high-grade lesions? Hum Pathol. 2005;36:1101\u20137.","journal-title":"Hum Pathol"},{"key":"2194_CR19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.bjc.6605123","volume":"101","author":"M Unoki","year":"2009","unstructured":"Unoki M, Kelly JD, Neal DE, Ponder BA, Nakamura Y, Hamamoto R. UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer. 2009;101:98\u2013105.","journal-title":"Br J Cancer"},{"key":"2194_CR20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bjc.6605717","volume":"103","author":"M Unoki","year":"2010","unstructured":"Unoki M, Daigo Y, Koinuma J, Tsuchiya E, Hamamoto R, Nakamura Y. UHRF1 is a novel diagnostic marker of lung cancer. Br J Cancer. 2010;103:217\u201322.","journal-title":"Br J Cancer"},{"key":"2194_CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1356-9597.2004.00710.x","volume":"9","author":"Y Arima","year":"2004","unstructured":"Arima Y, Hirota T, Bronner C, et al. Down-regulation of nuclear protein ICBP90 by p53\/p21Cip1\/WAF1-dependent DNA\u2014damage checkpoint signals contributes to cell cycle arrest at G1\/S transition. Genes Cells. 2004;9:131\u201342.","journal-title":"Genes Cells"},{"key":"2194_CR22","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1091\/mbc.E05-03-0194","volume":"16","author":"Y Jenkins","year":"2005","unstructured":"Jenkins Y, Markovtsov V, Lang W, et al. Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Mo. Biol Cell. 2005;16:5621\u20139.","journal-title":"Mol Biol Cell"},{"key":"2194_CR23","first-page":"3165","volume":"22","author":"R Hopfner","year":"2002","unstructured":"Hopfner R, Mousli M, Oudet P, Bronner C. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression. Anticancer Res. 2002;22:3165\u201370.","journal-title":"Anticancer Res"},{"key":"2194_CR24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cncr.25531","volume":"117","author":"A Daskalos","year":"2011","unstructured":"Daskalos A, Oleksiewicz U, Filia A, et al. UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. Cancer. 2011;117:1027\u201337.","journal-title":"Cancer"},{"key":"2194_CR25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1128\/MCB.01598-07","volume":"28","author":"P Karagianni","year":"2008","unstructured":"Karagianni P, Amazit L, Qin J, Wong J. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol Cell Biol. 2008;28:705\u201317.","journal-title":"Mol Cell Biol"},{"key":"2194_CR26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-009-0652-2","volume":"123","author":"W Jin","year":"2010","unstructured":"Jin W, Chen L, Chen Y, et al. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res Treat. 2010;123:359\u201373.","journal-title":"Breast Cancer Res Treat"},{"key":"2194_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cell.2006.10.003","volume":"127","author":"WY Kim","year":"2006","unstructured":"Kim WY, Sharpless NE. The regulation of INK4\/ARF in cancer and aging. Cell. 2006;127:265\u201375.","journal-title":"Cell"},{"key":"2194_CR28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1200\/JCO.2001.19.2.299","volume":"19","author":"M Esteller","year":"2001","unstructured":"Esteller M, Gonzalez S, Risques RA, et al. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer. J Clin Oncol. 2001;19:299\u2013304.","journal-title":"J Clin Oncol"},{"key":"2194_CR29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/bjc.1996.333","volume":"74","author":"RJC Slebos","year":"1996","unstructured":"Slebos RJC, Baas IO, Clement M, et al. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21(WAF1\/Cip1) in colorectal carcinoma. Br J Cancer. 1996;74:165\u201371.","journal-title":"Br J Cancer"},{"key":"2194_CR30","first-page":"565","volume":"61","author":"WC Yang","year":"2001","unstructured":"Yang WC, Mathew J, Velcich A, et al. Targeted inactivation of the p21(WAF1\/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosa. Cancer Res. 2001;61:565\u20139.","journal-title":"Cancer Res"},{"key":"2194_CR31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.cgt.7700480","volume":"9","author":"I Tamm","year":"2002","unstructured":"Tamm I, Schumacher A, Karawajew L, et al. Adenovirus-mediated gene transfer of P16INK4\/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo. Cancer Gene Ther. 2002;9:641\u201350.","journal-title":"Cancer Gene Ther"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-2194-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-011-2194-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-2194-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:46:02Z","timestamp":1572954362000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-011-2194-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,5]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["2194"],"URL":"https:\/\/doi.org\/10.1245\/s10434-011-2194-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,5]]}}}